Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Combating cigarette smoking-induced COPD through Dual Bronchodilators

JNU School of Biotechnology Research Job Openings For Life Science

The Age of Dinosaurs: Birth of humans as a social animal

Combating cigarette smoking-induced COPD through Dual Bronchodilators
  • BiotechToday
  • World

Combating cigarette smoking-induced COPD through Dual Bronchodilators

bioxone November 4, 2020November 4, 2020

Chitra Roy, University of Calcutta

Cigarette smoking is one of the major risk factors and causes of chronic obstructive pulmonary disease (COPD). Cigarette smoking accounts for almost 90% of COPD risk. Smoking can destroy the lung parenchyma and also contribute to the development of emphysema in which the walls of the air sacs(alveoli) in the lungs gets damaged leading to significant changes in the airway dynamics in bronchial tubes with impaired gas exchange and progressive air trapping, all of which is a characteristic of COPD. Cigarette smoking also induces the macrophages the release various neutrophil chemotactic factors and elastases which ultimately damages the tissues. Moreover, secondhand smoke or environmental tobacco smoke also increases the risks of respiratory infections which can lead to a measurable reduction in pulmonary function. 

COPD severity is found to be correlated with the extent of cigarette smoking. In smokers, it induces cell death in structural lung cells which is responsible for emphysema and COPD development. The epithelial cells of the alveoli function as a protective barrier in preserving the pulmonary function. These epithelial cells are vulnerable to insults from cigarette smoke (CS)/cigarette smoke extract (CSE) exposure which induces apoptosis (programmed cell death) and autophagy (self-eating/self-degradation). Therefore, protecting these epithelial cells from CS-induced alterations can show positive impacts. 

Tiotropium and olodaterol are bronchodilators which can regulate various components like M3R and β2AR that are involved in the cell death mechanism and can lead to the contraction and relaxation of airway smooth muscles, respectively. Tiotropium comes as an inhalation spray for long-term COPD treatment to reduce disease flare-ups. Olodaterol is a bronchodilator belonging to the class of drugs known as long-acting beta-agonists (LABA). Like most of the beta-agonists, olodaterol mimics the role of epinephrine at β2 receptors in the lung, which upon activation causes smooth muscles of the lungs to relax and the air spaces to open up and dilate hence improving patient’s respiratory performance.

 It was recently reported that tiotropium and olodaterol, as a dual bronchodilator had a better performance in reducing ROS-reactive oxygen species generation which can induce cell death. However, its mechanism is unclear. So, a team of researchers hypothesized that dual bronchodilators might impart some protective function to the epithelial cells upon exposure to CSE-mediated cell death. They used BEAS-2B (human bronchial epithelial cell line), and exposed these cells to various doses of CSE and performed cell viability assay-MTT assay and observed a reduction in cell viability indicating significant cell injury. To determine the effect of dual bronchodilators on CSE exposed cells, they pretreated the cell for 4hours with dual bronchodilators and then measured cell viability and observed it to increase. This indicated a protective role of using the combined bronchodilators. They also observed reduced mitochondrial dysfunction and increased autophagy activation. Using dual bronchodilators significantly reduced autophagy event. Their results indicated that tiotropium/olodaterol protects the bronchial epithelial cells from deleterious effects of CSE exposure which is related to autophagy regulation. This research successfully provides future insights to improve treatment plans for combating cigarette smoke-induced COPD by targeting autophagy mechanisms.

Also read: Does microbe in the gut protect against hazardous exposure ?

Reference: https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-020-00451-0

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged autophagy definition bronchodilator cigarette smoking copd full form copd meaning effects of cigarette smoking emphysema emphysema causes emphysema meaning lung epithelial cells smoking cigarette what is copd

3 thoughts on “Combating cigarette smoking-induced COPD through Dual Bronchodilators”

  1. Pingback: The Age of Dinosaurs: Birth of humans as a social animal - BioXone
  2. Pingback: Marine anammox bacteria (MAB) deals with nitrogen-burdened saline wastewater treatment and high UV irradiation simultaneously - BioXone
  3. Pingback: Vitamin D deficiency during pregnancy affecting brain development - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

The Age of Dinosaurs: Birth of humans as a social animal

bioxone November 5, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Scientists extracted remains from the Egg Mountain in Western Montana and studied the fossils of 22 individuals Filikomys primaeval (which translates to “youthful, friendly mouse”). The remains were about 75.5 million years old typically stuck together in groups of two to five, with at least 13 samples clustered within a […]

Dinosaurs

Related Post

  • BiotechToday
  • India

COVID UPDATE: Decrease in daily active cases in India

bioxone October 13, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Tocilizumab and Sarilumab receives WHO Approval for critically-ill Patients

BioTech Today July 9, 2021July 8, 2021

Agrima Bhatt, Rajasthan University Current Scenario The emergence of coronavirus from 2019 till now has led to a global healthcare crisis all over the world. Recent data of COVID-19 shows data as of July 7 having 184,324,026 confirmed cases and 3,992,680 deaths. Although vaccination has started to pick up pace in many countries, the risk […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

D614G: NEW CORONAVIRUS MUTATIONS MAKES THE VIRUS EIGHT TIMES MORE INFECTIOUS

bioxone February 19, 2021February 19, 2021

Aishila Kar, Amity University Kolkata The research, confirms findings that D614G — one of many mutations in the concerning variants that have emerged in the UK, South Africa, and Brazil — makes the coronavirus 8times more infectious. This novel coronavirus, D614G mutation in the spike protein renders it up to 8 times more infectious in […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy